Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Delluc, Aurélien
TILE, NCT04794569: Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome	Terminated	4	9	Canada	tinzaparin, Rivaroxaban	Sunnybrook Health Sciences Centre, LEO Pharma, Sunnybrook Research Institute	Deep Vein Thrombosis, Post Thrombotic Syndrome	01/24	01/24
SAVER, NCT04319627 / 2021-001559-15: Statins for Venous Event Reduction in Patients With Venous Thromboembolism	Recruiting	3	2700	Europe, Canada	Rosuvastatin Calcium, Rosuvastatin, Placebo Oral Tablet, Placebo	Ottawa Hospital Research Institute, The Canadian Institutes of Health Research (CIHR)	Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome	01/26	01/27
MVTEP2/SOME2, NCT04304651: Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism	Recruiting	N/A	1276	Europe, Canada	Limited cancer screening, Limited cancer screening + FDG PET/CT	University Hospital, Brest, Ministry of Health, France, Canadian Institutes of Health Research (CIHR), Ottawa Hospital Research Institute	Embolism and Thrombosis	09/26	09/30